Oral Rehabilitation of a Patient With Generalized Inflammatory Gingival Overgrowth Exacerbated by Felodipine: A Case Report

Cureus. 2022 Apr 21;14(4):e24332. doi: 10.7759/cureus.24332. eCollection 2022 Apr.

Abstract

Gingival enlargement may manifest as a side effect of medications (calcium channel blockers, anticonvulsants, or immunosuppressants) and may be associated with inflammation, malignancy, or genetic inheritance. This condition has a significant impact on a patient's quality of life and affects their oral health status. This case report describes the management of a 68-year-old gentleman who presented with generalized gingival enlargement and chronic periapical abscess originating from tooth 34, which served as an abutment for a fixed partial prosthesis. The patient's medical history revealed that felodipine, an antihypertensive medication, was prescribed to him. A comprehensive treatment plan was developed to improve the patient's quality of life.

Keywords: calcium channel blockers; felodipine; fixed prosthodontics; gingival hyperplasia; gingival overgrowth; hygienic pontic; sanitary pontic.

Publication types

  • Case Reports